Narcos

ADVERSE DRUG EFFECTS

To report the development of any adverse drug effect involving MDA products please complete the form below and submit to adrs@mdainc.ca.

molecule-f1

MDA pharmaceutical company’s approach

We are focused on the sale of hospital generic and specialty pharmaceuticals.

We principally target injectable products for hospital use however aim to provide a robust portfolio of products including difficult to source or manufacture drugs, with niche market applications.

MDA is a member of the Juno group.

JunoLogonew500

Latest News

Introducing: Caspofungin Acetate for Injection

  • April 20, 2017
  • MDA Inc.

    MDA is pleased to announce the launch of Caspofungin Acetate for Injection Product is now available in wholesalers. ...

Read more

MDA Pharmaceuticals partners with the Canadian Pharmaceutical Distribution Network (CPDN)

  • March 16, 2017
  • MDA Inc.

Oakville, Ontario – March 16, 2017 – MDA Pharmaceuticals is proud to announce a new partnership with the Canadian Pharmaceutical Distribution Network (CPDN), a leading distribution channel for pharmaceutical products to Canadian hospitals. After initially established as a contract promoter, MDA partnered with the Juno Pharmace...

Read more

Introducing: Solifenacin Succinate Tablets

  • January 5, 2017
  • MDA Inc.

MDA is pleased to announce the launch of Solifenacin Succinate Tablets. Product is now available in wholesalers. ...

Read more

Our new office telephone number

  • July 26, 2016
  • MDA Inc.

Please note that effective July 1st, our head office contact number has changed to 1-905-829-3838. Customer service can still be reached at 1-888-882-8827. ...

Read more

Introducing: Ketorolac

  • July 20, 2016
  • MDA Inc.

MDA is pleased to announce the launch of Ketorolac. Product is now available in wholesalers. ...

Read more

Introducing: Sevoflurane

  • July 20, 2016
  • MDA Inc.

MDA is pleased to announce the launch of Sevoflurane, generic equivalent to SojournTM. Product is now available in wholesalers. ...

Read more

Introducing: Zoledronic

  • July 20, 2016
  • MDA Inc.

MDA is pleased to announce the launch of Zoledronic, generic equivalent to ZometaTM. Product is now available in wholesalers. ...

Read more